Lipid treatment
Author:
Open Access
- 13 March 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Pharmacotherapy
- Vol. 11 (2) , 105-106
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Focus on lipid treatmentEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2023
- Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trialsEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2022
- Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registryEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2022
- Effects of renin–angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantationEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2022
- ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2European Heart Journal - Cardiovascular Pharmacotherapy, 2022
- Cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidenceEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2021
- Association between Aortic Calcification, Cardiovascular Events, and Mortality in Kidney and Pancreas-Kidney Transplant RecipientsAmerican Journal of Nephrology, 2019
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2019
- Echocardiography and lung ultrasonography for the assessment and management of acute heart failureNature Reviews Cardiology, 2017
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic StenosisNew England Journal of Medicine, 2008